1993PubMedRequires access

[Topical treatment of psoriasis with calcipotriol. Report of clinical experience].

Cornelia Hofmann, S Schirle

Open publisher page 1 citations

Abstract

BACKGROUND: Numerous clinical studies have demonstrated the efficacy of calcipotriol, a synthetic vitamin D3 analogue, in the treatment of mild to moderate chronic psoriasis. METHOD: Report on clinical experience of 40 psoriasis patients treated with calcipotriol, alone or in combination with phototherapy. RESULTS: After four weeks of treatment, the condition had largely cleared up in eleven out of 18 patients (61%) receiving calcipotriol alone, and in 20 out of 22 patients (91%) receiving combination treatment with UVB or UVA plus UVB. The new anti-psoriasis agent was well tolerated and readily accepted by the patients. CONCLUSION: Calcipotriol represents a valuable addition to the available therapy spectrum in chronic psoriasis.

About this research paper

What this paper is about

BACKGROUND: Numerous clinical studies have demonstrated the efficacy of calcipotriol, a synthetic vitamin D3 analogue, in the treatment of mild to moderate chronic psoriasis. METHOD: Report on clinical experience of 40 psoriasis patients treated with calcipotriol, alone or in combination with phototherapy. RESULTS: After four weeks of treatment, the condition had largely cleared up in eleven out of 18 patients (61%) receiving calcipotriol alone, and in 20 out of 22 patients (91%) receiving combination treatment with UVB or UVA plus UVB. The new anti-psoriasis agent was well tolerated and readily accepted by the patients. CONCLUSION: Calcipotriol represents a valuable addition to the available therapy spectrum in chronic psoriasis.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

BACKGROUND: Numerous clinical studies have demonstrated the efficacy of calcipotriol, a synthetic vitamin D3 analogue, in the treatment of mild to moderate chronic psoriasis. METHOD: Report on clinical experience of 40 psoriasis patients treated with calcipotriol, alone or in combination with phototherapy. RESULTS: After four weeks of treatment, the condition had largely cleared up in eleven out of 18 patients (61%) receiving calcipotriol alone, and in 20 out of 22 patients (91%) receiving combination treatment with UVB or UVA plus UVB. The new anti-psoriasis agent was well tolerated and readily accepted by the patients. CONCLUSION: Calcipotriol represents a valuable addition to the available therapy spectrum in chronic psoriasis.

Key concepts: Calcipotriol, Psoriasis, Medicine, Dermatology, Clearance, Ultraviolet therapy, Urology

Related papers

Back to paper searchBrowse research topicsOriginal source
[Topical treatment of psoriasis with calcipotriol. Report of clinical experience]. — Research Paper | ScholarLens